Navigation Links
Best Practice Database Adds Research on New Product Commercialization
Date:6/25/2008

CHAPEL HILL, N.C., June 25 /PRNewswire/ -- New research that explores the tactics and strategies that lead to successful product development, launch and management is now available in the Best Practice Database, an online research repository managed by research and consulting firm Best Practices, LLC.

To review sample key findings and key metrics in these studies, go to a landing page with links to each study at this address: http://www3.best-in-class.com/dr319.htm

The Database is an online resource containing more than $30 million in proprietary research conducted on behalf of executives from Fortune 500 companies. You can use this tool to quickly locate studies that identify best practices and metrics in the areas most important to you and your company.

Research added this month to the Best Practice Database includes a benchmarking study on the key success factors in new product commercialization for pharmaceutical and biotechnology companies. Experienced new product commercialization leaders noted that lifecycle management is emerging as a critical new skill in the hands of early-stage marketers. Once the domain of brand teams seeking to manage patent expirations in late-stage products, lifecycle management is taking on new meaning in the early commercialization process. More than ever, early-stage marketers seek to evaluate the full potential of new and existing molecular entities.

Also new to the Database this month are two case studies that deliver insights into the successful product launch of a therapy with a new mechanism of action and reinvigoration of a mature brand.

The new research is available in these Best Practice Database Documents (with ID Number):

-- Best Practices in New Product Commercialization (5001)

-- Requip Case Study: Life Cycle Management - Reinvigorating a Mature Brand (5000)

-- Cymbalta Case Study: Successfully Entering a Crowded Market with a New Mechanism of Action (5002)

To view these studies or other studies in the Database, sign up for our complimentary weekly tour, held on Thursdays at 11 a.m. EDT (GMT-5). To sign up, go to this address: http://www3.best-in-class.com/dw212.htm . If you prefer a different time, simply indicate your preference on the sign up form.

To review abstracts and other information about these studies, go to a landing page with links to each study at this address: http://www3.best-in-class.com/dr319.htm

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, a pharmaceutical research and consulting firm, conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class organizations. For more information, call 919-403-0251 or visit http://www.best-in-class.com/ .


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Behavioral Risk in the Workplace: Behavioral Risk Management Continues to be an Important Best Practice Area for Employers
2. Martin Memorial Health Systems Selects Allscripts for Electronic Health Record and Practice Management
3. Best Practices: Achieving Excellence in Staffing and Recruiting Methods
4. High-Performing Sales Forces Share Key Practices to Achieve Optimal Performance
5. Kingfisher Healthcare (KFH) Wins Prestigious Frost & Sullivan Best Practices Award
6. Best Practice Database Supports Bio-Pharma M&A Integration with New Publication
7. Edge Health Solutions Releases edgeDMS(TM) 2.0 and edgeMD 2.0(TM), Revolutionary All-in-One Practice Management Software with FDA-Approved Advanced Visualization
8. Rush-Copley Medical Center Selects Allscripts Electronic Health Record and Practice Management Solution
9. Best Practices, LLC: Create Strong Leadership to Add Value to Market Research Function
10. Best Practice Toolkit Supports Recruitment of Top Clinical Investigators
11. Best Practices in Sales Recognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... Aviv, Israel (PRWEB) , ... April 26, 2017 , ... ... today announced a new partnership with Med-e-Mass , the largest Electronic Medical Records ... enable Med-e-Mass to link care plan incentives to a patient’s remote health progress, empowering ...
(Date:4/26/2017)... ... ... Miami native and local periodontist Dr. John Paul Gallardo is ... in 1991 that this journey would have taken me into so many learning experiences ... Gallardo has pioneered implant dentistry innovation, evolving into an internationally recognized leader in the ...
(Date:4/26/2017)... (PRWEB) , ... April 26, ... ... which provides an agile ecosystem and domain expertise for sponsors and CROs ... randomization and trial supply management (RTSM) software platform. Bioclinica AGILE RTSM ...
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from ... performance for the 2015-16 school year across Wisconsin’s public schools, charter schools, and ... important patterns in student test score performance, the report’s limited analyses fail to ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
(Date:4/19/2017)... LONDON , April 19, 2017 ... to stimulate an immune response in pets such ... vaccine products are of various types such as ... Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. ... such as virus or bacteria, which have been ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: